K
The startup develops a micro physiological system utilizing human-only tissues and cells to create accurate models for solid tumors in the breast, colon, and prostate. This technology enables medical practitioners to replicate the native physiology and pathophysiology of cancer, enhancing the reliability of experimental outcomes.
Updated 3 months ago
Funding
$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a micro physiological system utilizing human-only tissues and cells to create accurate models for solid tumors in the breast, colon, and prostate. This technology enables medical practitioners to replicate the native physiology and pathophysiology of cancer, enhancing the reliability of experimental outcomes.